A total of 106 records were obtained from initial hits, and seven papers were obtained from cross-referencing. After removing duplicates, 49 studies were subjected to title and abstract screening, and 22 reached the full-text screening stage after removing 27 irrelevant studies. Five full-text studies were excluded (Fig. 2), and 15 studies were ultimately included in this review and meta-analysis. A PRISMA flow diagram explains the process of including the studies in the systematic review.
Study Characteristics
Among the 15 included studies, four were randomized controlled trials (RCTs) (21–24) and 11 were quasi-experimental designs, all published between 2000 and 2024 (25–35)(Table 4). These studies primarily investigated the effectiveness of aromatherapy in managing dysmenorrhea, focusing on adolescents aged 10–19 years (n = 10) and young adults aged 20–24 years (n = 5) across the globe regardless of geographical location.
Interventions primarily involved aromatherapy using essential oils such as lavender, cinnamon, rose, lemon, and peppermint. Eight studies utilized inhalation methods, where participants inhaled oils applied to gauze, palms, or through a necklace, with inhalation durations ranging from 5 to 20 minutes (22, 25, 28, 30–32, 34, 35). Aromatherapy massage was featured in six studies, predominantly using lavender oil (n = 6), either alone or combined with oils like clary sage and rose (21, 23, 24, 27, 29, 33). Massage techniques included effleurage, which is characterized by gentle, rhythmic strokes on the abdomen (effleurage) that last 10 to 15 minutes per session and are applied daily or intermittently around menstruation.
Table 4: Characteristics of the included studies
Author’s first name
|
Study design (sample size)
|
Type of blinding
|
Age range (years)
|
Intervention group (regime)
|
Aroma oils
|
Control group (regime)
|
Main outcome measures (scale)
|
Significant or insignificant
|
Key findings
|
Serap (2012)(33)
|
Quasi-experimental study
(n-44)
|
NA
|
*20.31±1.09
|
aromatherapy massage (efflurage) at a fixed time of the day by the same massager for 15 mins on the abdomen in a special quiet room where the temperature was between 23 C and 25 C (73.4 F and 77 F).
|
Lavender
|
placebo massage (effleurage) with odorless liquid petrolatum (soft paraffin) at a fixed time of the day by the same massager for 15 mins on abdomen in a special quiet room where the temperature was between 23 C and 25 C (73.4 F and 77 F).
|
VAS
|
P<0.001
|
Aromatherapy massage with lavender oil was more effective in reducing dysmenorrhea compared to placebo massage.
|
Niasty et al (2021)(28)
|
Quasi experimental design (n=44)
|
NA
|
15-18
|
All students who received aromatherapy via inhalation for 15 minutes while experiencing dysmenorrhea.
|
Cinnamon (Cinnamomum burmanii)
|
No treatment or therapy was provided in preintervention phase
|
Pain scale with categories like "very annoying pain", "slight pain", and "very bothersome pain"
|
P<0.001
|
The key findings are: 1) Primary dysmenorrhea pain was experienced by the majority of students before the intervention, with most reporting "disturbing pain". 2) After the intervention of cinnamon aromatherapy, the majority of students reported experiencing "a bit of pain", indicating a significant reduction in pain. 3) The statistical analysis showed a significant effect of the cinnamon aromatherapy on reducing primary dysmenorrhea pain.
|
Husnul et al (2021)(27)
|
Quasi Experimental Design (n=60)
|
NA
|
Adolescents (age not mentioned)
|
The intervention group received acupressure therapy using lemon essential oil aromatherapy at points LI 11, LI 4, and ST 36 on days 1-2 of menstruation.
|
Lemon essential oil aromatherapy
|
The control group (preintervention) received acupressure therapy without using aromatherapy.
|
Numerical visual analog scale (VAS) with a pain intensity scale ranging from 0-10
|
p<0.001
|
Acupressure using aromatherapy is effective in reducing dysmenorrhea (menstrual pain) in teenage students, and is more effective than acupressure alone.
|
Yuni et al (2018)(29)
|
Quasi-experimental, time series method (n=40)
|
NA
|
15-18
|
Effleurage massage using lavender aromatherapy, where the lavender essential oil was diluted in olive oil, and the massage was performed for 10 minutes, repeated after 6 hours (n=22)
|
a mixture of lavender essential oil and olive oil
|
The control group did not take any action (n=22).
|
Numerical rating scale: 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, 7-9 = severe pain, 10 = very severe pain
|
p<0.001
|
The use of lavender aromatherapy combined with effleurage massage was effective in reducing menstrual pain (dysmenorrhea) in high school students, as shown by a significant reduction in pain levels compared to control groups.
|
Dwi et al (2021)(25)
|
Quasi experimental, n= 22
|
NA
|
14-17
|
Inhalation aromatherapy to reduce dysmenorrhea (menstrual pain) in teenage girls.
|
Lavender oil
|
No intervention
|
Lavender aromatherapy questionnaire, the dysmenorrhea scale
|
P<0.01
|
Lavender aromatherapy was effective in reducing dysmenorrhea (menstrual pain) in teenage girls.
|
Yeti et al (2022)(30)
|
Quasi experimental using two groups (n=30)
|
NA
|
18-19
|
Aromatherapy for 1 hour
|
Lavender essential oil
|
Warm compression for 1 hour
|
Numeric Rating Scale (NRS)
|
P<0.001
|
Both warm compresses and lavender aromatherapy were effective in reducing dysmenorrhea pain, with no significant difference between the two interventions.
|
Froozan et al (2015)(21)
|
RCT (crossover design)
|
Not mentioned
|
18-24
|
Aromatherapy massage with rotation movements using both hands without creating pressure on the abdomen for 15 min.
|
Lavender essential oil
|
Placebo massage with rotation movements using both hands without creating pressure on the abdomen for 15 min.
|
VAS with 10 point ruler
|
P<0.001
|
Massage with lavender essential oil resulted in a significantly greater reduction in the severity of dysmenorrhea compared to placebo massage alone, and lavender oil appears to have a more important role in reducing pain severity than other essential oils.
|
Rahayu et al (2019)(32)
|
Quasi Experimental Design (n=34)
|
NA
|
Teenage girls of grade X and XI (age not mentioned)
|
Inhalation aromatherapy for 20 minutes, using 3 drops of lavender essential oil mixed with 20 ml of water
|
Lavender oil
|
No treatment in pre intervention phase
|
Menstrual pain scale (10 points)
|
P<0.001
|
Lavender aromatherapy is effective in reducing the level of dysmenorrhea (menstrual pain) in adolescent girls.
|
Lika et al (2022)(31)
|
Quasi experimental study (n=30)
|
NA
|
15-17
|
Inhalation aromatherapy
|
Cinnamon aromatherapy
|
No treatment in preintervention phase
|
Menstrual pain or dysmenorrhea, measured on a scale from 0 to 3, with 0 indicating no pain and 3 indicating severe pain.
|
NS
|
Cinnamon aromatherapy intervention significantly reduced the intensity of primary dysmenorrhea in the study participants, with the average pain score decreasing from 6.067 before the intervention to 3.100 after the intervention. The paired t-test showed a significant difference in anxiety levels before and after the intervention, with a p-value of 0.000.
|
Selda et al (2023)(22)
|
RCT
|
Open label
|
*21.51 ± 1.63
|
The intervention group (group R) received both standard analgesic treatment (diclofenac sodium 50 mg enteric film tablets) and inhalation aromatherapy with rose oil (Rosa damascena Mill.)
|
essential rose oil (Rosa damascena Mill.)
|
The control group (group C) only used standard analgesics (50 mg diclofenac sodium enteric film tablets).
|
pre-treatment (VAS-0) and post-treatment (VAS-
60)
|
P<0.05
|
Inhalation of rose oil (Rosa damascena Mill.) in addition to standard NSAID treatment for primary dysmenorrhea led to lower pain scores and lower total analgesic consumption compared to NSAID treatment alone. Rose oil aromatherapy by inhalation can be a good self-treatment option for primary dysmenorrhea, either alone or as an additional method to avoid excessive NSAID use and side effects.
|
Farida et al (2023)(26)
|
Quasi experimental design (n=30)
|
NA
|
15-16
|
Cinnamon aromatherapy for 15 minutes when experiencing menstrual pain.
|
Cinnamon aromatherapy
|
No treatment during preintervention phase
|
Numeric rating scale using categorization into mild (1-3), moderate (4-6), severe (>7)
|
P<0.001
|
cinnamon aromatherapy had a significant effect in reducing the intensity of primary menstrual pain among the female students. After the treatment, the majority of students (63.3%) experienced mild pain, compared to 46.7% experiencing moderate pain before the treatment. The statistical analysis showed a significant difference in pain levels before and after the treatment.
|
Leza et al (2024)(24)
|
RCT (n=40)
Intervention (n=20)
Control (n=20)
|
Open label
|
18-24
|
3% peppermint lotion 3 times a day for 3 days,
|
Peppermint oil lotion
|
The control group received a placebo lotion, administered 3 times per day for 3 days.
|
Pain intensity (Numeric Rating Scale) and cortisol levels (blood serum)
|
P<0.05
|
Administration of peppermint lotion for 3 days reduced pain intensity and cortisol levels in adolescents with primary dysmenorrhea, with statistically significant differences between the intervention and control groups.
|
Sun-Hee et al (2006)(23)
|
RCT (n=67)
Intervention (n=25)
Control (n=20)
|
Double
|
*20.6 ± 1.27
|
15-minute abdominal massage using a blend of lavender, clary sage, and rose essential oils (2:1:1 ratio) diluted in almond oil at a 3% concentration, applied daily starting one week before the start of menstruation and continuing until the first day of menstruation.
|
A blend of lavender, clary sage, and rose essential oils diluted in almond oil at a 2:1:1 ratio and 3% concentration
|
The control group received no treatment and continued their daily routine.
|
The main outcome measures were:
1) Intensity of menstrual cramps, measured using a 10-point Visual Analogue Scale (VAS)
2) Severity of dysmenorrhea, measured using a verbal multidimensional scoring system with 4 grades (1 = none, 2 = mild, 3 = moderate, 4 = severe)
|
P<0.001
|
Aromatherapy using a blend of lavender, clary sage, and rose essential oils significantly reduced menstrual cramps and the severity of dysmenorrhea compared to placebo and control groups.
|
Thenmozhi et al (2020)(35)
|
Quasi experimental study (n=60)
|
NA
|
17-19
|
Aromatherapy was administered by inhalation method in alternate days from 7th day of menstrual cycle for two consecutive menstrual cycles. It was administered by sprinkled few drops of lavender essential oil onto a clean and sterile tissue and instructed the participants to inhale its aroma.
|
Lavender essential oil
|
No therapy before intervention
|
The main outcome measure was a 27-item primary dysmenorrhea symptom assessment questionnaire that covered physiological and psychological symptoms, as well as a numerical pain rating scale.
|
P<0.001
|
Aromatherapy using lavender oil was effective in reducing menstrual distress, including physical symptoms like nausea and back ache, as well as improving concentration and sleep, in adolescent girls with primary dysmenorrhea. The therapy was also inexpensive, easy to administer, safe, and affordable, making it a recommended treatment in both clinical and community settings.
|
Sri Sat et al (2019)(34)
|
Quasi experimental study (n=16)
|
NA
|
16-17
|
Lavender aromatherapy, where 3-5 drops of lavender essential oil were inhaled for 5 minutes
|
Lavender essential oil
|
NA
|
NRS (Numeric Rating Scale)
|
P<0.001
|
Lavender aromatherapy was effective in reducing menstrual pain in female teenagers, with a significant decrease in pain score from 3.69 to 2.06 after the intervention.
|
Abbreviations: VAS: Visual Analogue Scale, NRS: Numeric Rating Scale, RCT: Randomized Controlled Trial, NA: Not Applicable, NSAID: Non-Steroidal Anti-Inflammatory Drug
aAge: mean±SD
Among the RCTs, blinding procedures were noted, ensuring participants and/or assessors were unaware of the treatment allocation to minimize bias. For instance, Han et al. (2006) used a double-blind method in their study involving a blend of lavender, clary sage, and rose essential oils, diluted in almond oil, demonstrating significant reductions in menstrual cramps and dysmenorrhea severity (23). Meliya et al. (2024) utilized an open-label approach for young females (24). Additionally, one study by Khotimah et al. (2021) integrated acupressure therapy with lemon essential oil aromatherapy, focusing on adolescents, though specific age ranges were not always specified.(27)
Control groups in these studies received no treatment, placebo massages using odorless oils, or standard analgesic treatments. Outcome measures included pain intensity assessed via scales like the Visual Analogue Scale (VAS) (36), Numeric Rating Scale (NRS) (37), and specific dysmenorrhea questionnaires (38). Most studies reported substantial decreases in pain scores post-intervention, affirming the efficacy of aromatherapy in managing dysmenorrhea symptoms. The duration and frequency of interventions varied, with consistent findings indicating that aromatherapy, particularly with lavender oil, provides a promising non-invasive approach for alleviating menstrual pain.
Risk of bias assessment
Regarding study quality assessment, the included randomized controlled trials (RCTs) were rated as high quality due to their low risk of bias (21–24). These studies employed rigorous methodologies such as randomization and blinding, enhancing the reliability of their results. On the other hand, the quasi-experimental studies were deemed low quality overall, with a majority categorized as having serious risk of bias. Specifically, two of these quasi-experimental studies were assessed to have a critical risk of bias (32,33). This rating reflects potential methodological limitations in study design.
Figure 3a and b illustrates the risk of bias graph and summary plot for the RCTs, highlighting their methodological strengths. Conversely, Figure 4a and b depicts these assessments for the quasi-experimental studies, emphasizing the variability and lower quality of their methodological approaches.
Findings from Meta-analysis:
Randomized controlled trials
RCT meta-analysis included four studies and used menstrual pain as a continuous variable (Figure 5) (21–24). Given the significant heterogeneity among the studies (I² = 64), a random-effects model was applied. The pooled SMD was -0.98 (95% CI: -1.40, -0.57), indicating a moderate reduction in menstrual pain among participants who received aromatherapy compared to the control group. These results demonstrate that aromatherapy significantly alleviates primary dysmenorrhea, with the findings being statistically significant (p < 0.001).
The funnel plot for the RCTs included in the meta-analysis (Figure 6) demonstrates the relationship between each study's standard error and SMD. The plot is symmetrical, indicating no significant publication bias among the included studies. The scatter of the points around the vertical dashed line at zero suggests that the effect sizes from individual studies are evenly distributed on both sides, further supporting the absence of bias. However, the plot does show some variability in the standard errors, which is expected given the differences in study sample sizes and methodologies.
Quasi-experimental studies
Among the 11 quasi-experimental studies, we conducted a meta-analysis using two different approaches: continuous and categorical data. Six studies reported menstrual pain as a continuous variable with mean scores(30–35). For these studies, we calculated the standardized mean difference (SMD) (Figure 7a). Given the high heterogeneity (I² of 98%), a random effects model was applied, yielding a pooled SMD of -3.19 (95% CI: -5.09 to -1.28) with a p-value of 0.001. This result indicates a significant reduction in menstrual pain with aromatherapy. On the other hand, five studies reported pain categorically, focusing on the prevalence of moderate to severe menstrual pain (Figure 7b) (25–29). Using a random effects model, the relative risk (RR) was found to be 0.39 (95% CI: 0.25-0.60) with an I² of 36%. This result was also statistically significant with a p-value of <0.001, further supporting the efficacy of aromatherapy in relieving menstrual pain.
Funnel plot
Funnel plots with 95% confidence intervals (CIs) for quasi-experimental studies on the effect of aromatherapy on menstrual pain relief are shown in Figure 8. The plot in Figure 8a depicts the Standardized Mean Differences (SMDs) for continuous data, with the SMDs (x-axis) plotted against their standard errors (SEs) (y-axis). The plot in Figure 8b shows the Risk Ratios (RRs) for categorical data, with the log-scale RRs (x-axis) plotted against their standard errors (SEs) (y-axis). The visual inspection of these plots suggests some asymmetry, indicating potential publication bias or heterogeneity in the study outcomes.
Subgroup Analysis
We conducted subgroup analyses to evaluate the overall effect of aromatherapy on menstrual pain across age groups (adolescents and young adults), modes of aromatherapy application, and types of aroma oils (Figure 9). Adolescents showed a significant reduction in pain risk (RR 0.39; CI 0.25, 0.60; I2 36) and a substantial decrease in pain intensity (SMD -3.64; CI -6.24, -1.03; I2 98) ((25–29,31,32,34) (26,30). Young adults exhibited moderate pain reduction (SMD: -1.04, CI -1.35,-0.72; I2 53) (21–24,33). Massage also moderately reduced pain intensity (SMD: -1.20, CI -1.45, -0.96; I2 7 ; RR: 0.58, CI 0.34,0.99; I2 0), while inhalation had a more substantial effect (SMD: -3.09, CI -5.06, -1.12; I2 98; RR 0.20; CI 0.10, 0.39; I2 0%). Peppermint rose and cinnamon oils appeared most effective in alleviating menstrual pain, showing modest to moderate reductions in pain intensity (22,24,26,28,31). Lemon oil showed no significant effect (RR:0.60; CI 0.25,1.44) (27), while lavender did not significantly reduce moderate to severe pain (SMD:-2.85; CI -4.28,-1.41; I2 97; RR 0.38; CI 0.11,1.32; I2 45) (21,23,29,30,32–35).
Other outcomes
Aromatherapy impacts various aspects of menstrual health beyond pain relief. Analgesic consumption was significantly lower in participants receiving aromatherapy compared to controls (50 mg [50–100] vs. 100 mg [50–100]; p = 0.003). Mean pain scores measured during the second and third cycles showed no significant differences, indicating that time did not affect menstrual pain among those receiving the intervention or control (21). One study reported a significant reduction in cortisol levels in the intervention group (MD 2.64) compared to the control group (MD 0.94; p = 0.010) after aromatherapy administration (24). Additionally, primary dysmenorrhea-related parameters were assessed, revealing that 59% of adolescent girls with dysmenorrhea were stressed, only 12% sought medical advice, and only 12% were prescribed treatment therapy (25,35). Furthermore, 88% of adolescents with dysmenorrhea skipped meals (35). There was also a statistically significant association between the duration of the menstrual cycle and the pre-intervention level of menstrual distress among adolescent girls with primary dysmenorrhea (p < 0.05) (35). Overall, QoL was not measured in any of the studies.